EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieOpen Access · CC BY 4.0

Determinants of preterm pre‐eclampsia following low‐dose aspirin prophylaxis: evidence from stepped‐wedge cluster randomized trial in Asia

J Lin iD, L Nguyen-Hoang iD, L T Dinh, R K Pooh, A Ohkuchi iD, M Zheng iD, Y Wu, A Kusuma iD, T Wataganara iD, M Choolani, M Kaneko iD, S Luewan iD und 7 weitere

Ultrasound in Obstetrics & Gynecology · 2026-10 · 68 (4) · 492-503

DOI: 10.1002/uog.70339 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Ultrasound in Obstetrics & Gynecology, online erschienen am 27.09.2026. Verfasst von J Lin und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynaecology, The Chinese University of Hong Kong, Shatin, Hong Kong SAR, China. Hauptthemen laut MEDLINE: Pre-Eclampsia, Aspirin, Platelet Aggregation Inhibitors. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To identify potential risk factors – among maternal factors, pre‐eclampsia (PE)‐specific biomarkers and estimated risks derived from the first‐trimester Fetal Medicine Foundation (FMF) triple test – that are associated with the subsequent development of preterm PE, and to evaluate predictors of any‐onset PE using time‐to‐event analysis, in high‐risk women receiving low‐dose aspirin prophylaxis.

Methods

This was a secondary analysis of a multicenter stepped‐wedge cluster randomized trial, including 18 maternity/diagnostic units from 10 regions in Asia between August 2019 and February 2022. The study population comprised women with a singleton pregnancy identified as being at high risk for preterm PE (estimated risk ≥ 1:100) according to the first‐trimester FMF triple test, who subsequently received low‐dose aspirin prophylaxis. A locally estimated scatterplot smoothing (LOESS) curve was applied initially to explore the relationship between the incidence of preterm PE and the estimated risk. Based on the trend observed in the LOESS curve, participants were categorized into five estimated risk groups: 1:2 to 1:5, 1:6 to 1:10, 1:11 to 1:20, 1:21 to 1:50 and 1:51 to 1:100. Logistic and Cox regression analyses were performed to identify independent predictors of preterm PE and to evaluate the risk of delivery with PE, respectively.

Results

Among 2919 high‐risk pregnant women receiving aspirin prophylaxis, 280 (9.6%) developed PE, including 107 (3.7%) who developed preterm PE. Chronic hypertension (adjusted odds ratio (aOR), 1.835 (95% CI, 1.070–3.146)), mean arterial pressure (MAP) multiples of the median (MoM) > 1.149 (aOR, 2.162 (95% CI, 1.434–3.261)) and higher estimated risk were associated with higher odds of preterm PE. Compared to women with an estimated risk of 1:51 to 1:100, those with estimated risks of 1:2 to 1:5, 1:6 to 1:10 and 1:11 to 1:20 had a 16‐fold (aOR, 15.845 (95% CI, 8.166–30.746)), eight‐fold (aOR, 7.674 (95% CI, 3.925–15.004)) and three‐fold (aOR, 3.454 (95% CI, 1.802–6.622)) higher odds of developing preterm PE, respectively, whereas no significant difference was observed in those with an estimated risk of 1:21 to 1:50 (aOR, 1.343 (95% CI, 0.722–2.499)). On Cox regression analysis, chronic hypertension was associated with a three‐fold higher risk of delivering with PE (adjusted hazard ratio (aHR), 2.979 (95% CI, 2.154–4.120)), while MAP MoM > 1.149 increased the risk by 66% (aHR, 1.659 (95% CI, 1.304–2.111)). Compared with the reference group (estimated risk of 1:51 to 1:100), the risk of delivering with PE increased progressively across estimated risk groups, with aHRs of 1.435 (95% CI, 1.051–1.959), 2.408 (95% CI, 1.653–3.508), 4.058 (95% CI, 2.658–6.197) and 7.053 (95% CI, 4.588–10.841) for the 1:21 to 1:50, 1:11 to 1:20, 1:6 to 1:10, and 1:2 to 1:5 estimated risk groups, respectively.

Conclusions

Chronic hypertension, elevated MAP and higher estimated risk are associated with the earlier development of PE in women identified as high risk by the first‐trimester FMF triple test, despite low‐dose aspirin prophylaxis. Incorporating these factors into the risk stratification framework may improve the detection of residual risk in first‐trimester screening and prevention strategies, thereby supporting the development of more effective preventive measures. © 2026 The Author(s). Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pre-EclampsiaAspirinPlatelet Aggregation InhibitorsHumansFemalePregnancyAdultRisk FactorsAsiaPregnancy Trimester, FirstBiomarkersIncidencePregnancy, High-Risk

Stichwörter der Autor:innen

AsiaFetal Medicine Foundationaspirinfirst trimesterlogistic regressionmean arterial pressuremulticenterplacental growth factorpretermpre‐eclampsiaresidual riskrisk factorstepped‐wedge cluster randomized trialtriple test

Substanzen

AspirinPlatelet Aggregation InhibitorsBiomarkers

Autor:innen und Institutionen

  • Department of Obstetrics and Gynaecology, The Chinese University of Hong Kong, Shatin, Hong Kong SAR, China.
  • Fetal Medicine Centre, Tam Anh HCMC General Hospital, Ho Chi Minh City, Vietnam.
  • Hanoi Obstetrics and Gynecology Hospital, Hanoi, Vietnam.
  • CRIFM Prenatal Medical Clinic, Osaka, Japan.
  • Department of Obstetrics and Gynecology, Jichi Medical University, Shimotsuke, Japan.
  • Nanjing Drum Tower Hospital affiliated to Nanjing University Medical School, Nanjing, China.

ORCID-Profile: J Lin, L Nguyen-Hoang, A Ohkuchi, M Zheng, A Kusuma, T Wataganara, M Kaneko, S Luewan, T-Y Chang, H Liu, S W Shaw, L C Poon

Förderung

  • Ministry of Science and Technology

Zitieren

APA

Lin, J., Nguyen-Hoang, L., Dinh, L. T., Pooh, R. K., Ohkuchi, A., Zheng, M., Wu, Y., Kusuma, A., Wataganara, T., Choolani, M., Kaneko, M., Luewan, S., Chang, T. Y., Chaiyasit, N., Nanthakomon, T., Liu, H., Shaw, S. W., Poon, L. C., & FORECAST collaborators (2026). Determinants of preterm pre‐eclampsia following low‐dose aspirin prophylaxis: evidence from stepped‐wedge cluster randomized trial in Asia. Ultrasound in Obstetrics & Gynecology, 68(4), 492-503. https://doi.org/10.1002/uog.70339

Vancouver

Lin J, Nguyen-Hoang L, Dinh LT, Pooh RK, Ohkuchi A, Zheng M, et al. Determinants of preterm pre‐eclampsia following low‐dose aspirin prophylaxis: evidence from stepped‐wedge cluster randomized trial in Asia. Ultrasound in Obstetrics & Gynecology. 2026;68(4):492-503. doi:10.1002/uog.70339

BibTeX
@article{Lin2026,
  author = {Lin, J and Nguyen-Hoang, L and Dinh, L T and Pooh, R K and Ohkuchi, A and Zheng, M and Wu, Y and Kusuma, A and Wataganara, T and Choolani, M and Kaneko, M and Luewan, S and Chang, T-Y and Chaiyasit, N and Nanthakomon, T and Liu, H and Shaw, S W and Poon, L C and FORECAST collaborators, FORECAST collaborators},
  title = {Determinants of preterm pre‐eclampsia following low‐dose aspirin prophylaxis: evidence from stepped‐wedge cluster randomized trial in Asia},
  journal = {Ultrasound in Obstetrics & Gynecology},
  year = {2026},
  volume = {68},
  number = {4},
  pages = {492--503},
  doi = {10.1002/uog.70339}
}
Kostenlos starten →